Amarin Corp Plc (AMRN)

[couldbebetter]

golf stud, I think BP already has figured out the value of Vascepa for
both CVD as well as COVID-19...to me it a logical conclusion that any
tests done with Vascepa for any measure of inflammation will result
in Vascepa lowering the inflammation. The COVID-19 trials will likely
prove out what we already suspect. As to the valuation obviously BP
will know the true cost of production in bulk...and the lower they
can sell it for the greater the amount of product they should be able
to sell. I used to think $40 a share would be reasonable and I honestly
believe that even at that cost BP would still be able to make a good
return. I too think anyone who believes that no deal could be done
that would be over $15 a share will be proven wrong in time. (I also
wonder if a BP acquirer could result in an FDA administrative action
that would end the generic skinny label uncertainty.) If Pfizer
owned AMRN I think Dr. Gottlieb would get the FDA to move swiftly
on a solution...especially if Vascepa received a designation as
an emergency COVID-19 medication.